Non-profit attracts four prominent members of wound care industry to expand limb-salvage mission
The Save A Leg, Save A Life Foundation recently voted in four well-regarded industry professionals to serve on the board, bringing the group to 12 members.
Matthew F. Myntti, Ph.D. is the Chief Technology Officer at Next Science. He has invented a number of innovative biofilm disinfection technologies and led the development of 5 commercially produced anti-biofilm products. Previously, he was President and V.P. of Research and Development at Next Science. He received his Master’s and Doctoral degrees in Materials Science and Engineering from the University of Dayton and has over 30 granted US patents. Dr. Myntti previously led the biomaterials group at Medtronic Surgical Technologies, which developed novel ENT and neurologic products.
Diane Weiss, CPC, CPB, CCP, CHRI, is Vice President, Revenue Integrity, Education and Vendor Relations at RestorixHealth. Previously, she managed a general surgery practice for 10 years in the Greater New Orleans area, where she served as practice manager and was the surgeon’s in-office medical assistant. She was the provider education representative for Pinnacle Medicare Services, providing CMS Medicare Part B provider education and denials management for providers throughout Louisiana and other states within the MAC’s jurisdiction. She is a recipient of the Health Ethics Trust “Healthcare Compliance Best Practice Award.”
Santino Costanzo has extensive experience in business leadership in the wound care and tissue engineering space, having recently retired as Chief Commercial officer of Omeza Inc. He was National Director of National Accounts at Organogenesis and had significant leadership roles in product commercialization and business development with Amniox Medical, Spiracur, Harbor MedTech, and Novartis Pharmaceuticals.
Colton Rahav, CEO and Founder of both Rahav Tech and Presthera, focuses on helping extremely under-served populations of patients struggling to keep their limbs due to diseases most often associated with socioeconomic conditions and self-care. In addition, he has experience bringing innovative and novel medical devices to market in the orthopedic and regenerative medicine markets.
Existent board members are Frank Aviles, Jr., President; Dr. Desmond Bell, Founder and President Emeritus; Carol Barry, Treasurer; Christine Grogan, Dr. M. Mark Melin, Karl Hindle, Dr. Alton R. Johnson, Jr.; and Annika Kariniemi.